Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% below its 5-year average of 3.08%, around the middle of its 5-year range (-192.70%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% above its 12-month average of -64.23%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
-64.23%
GROSS MARGIN AVG 3Y
-13.24%
GROSS MARGIN AVG 5Y
3.08%
GROSS MARGIN AVG 10Y
19.70%
GROSS MARGIN AVG 15Y
13.13%
GROSS MARGIN AVG 20Y
3.86%
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
41.03%
median of 851 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Incannex Healthcare Limited
Market Cap
$37.83M
Gross Margin
0.00%
TTM Avg
-64.23%
3Y Avg
-13.24%
5Y Avg
3.08%
Market Cap
$38.88M
Gross Margin
58.16%
TTM Avg
55.59%
3Y Avg
55.93%
5Y Avg
56.24%
Market Cap
$36.23M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
22.09%
Market Cap
$39.15M
Gross Margin
74.29%
TTM Avg
89.45%
3Y Avg
39.47%
5Y Avg
19.73%
Market Cap
$36.28M
Gross Margin
39.56%
TTM Avg
49.73%
3Y Avg
-33.76%
5Y Avg
-21.28%
Market Cap
$35.69M
Gross Margin
41.73%
TTM Avg
31.44%
3Y Avg
27.18%
5Y Avg
29.99%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $37.83M | 0.00% | -64.23% | -13.24% | 3.08% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.94M | 0.00% | 0.00% | 0.00% | 15.78% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.88M | 58.16% | 55.59% | 55.93% | 56.24% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.23M | 0.00% | 0.00% | 0.00% | 22.09% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.15M | 74.29% | 89.45% | 39.47% | 19.73% |
| Nephros, Inc. (NEPH)vs › | $36.37M | 60.31% | 61.36% | 57.30% | 56.95% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | 39.56% | 49.73% | -33.76% | -21.28% |
| DocGo Inc. (DCGO)vs › | $35.81M | 30.12% | 32.64% | 32.93% | 33.24% |
| EUDA Health Holdings Limited (EUDA)vs › | $35.69M | 41.73% | 31.44% | 27.18% | 29.99% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.34M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-06-30 | -192.70% |
| 2024-12-31 | 100.00% |
| 2024-06-30 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-06-30 | 78.53% |
| 2021-12-31 | 0.00% |
| 2021-06-30 | 48.08% |
| 2020-12-31 | 54.30% |
| 2020-06-30 | 8.03% |
| 2019-12-31 | -14.97% |
| 2019-06-30 | 0.36% |
| 2018-12-31 | 33.86% |
| 2018-06-30 | 54.06% |
| 2017-12-31 | 30.82% |
| 2017-06-30 | -91.04% |
| 2016-12-31 | 37.67% |
| 2016-06-30 | 23.87% |
| 2015-12-31 | 100.00% |
| 2015-06-30 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-06-30 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-06-30 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-06-30 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-06-30 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-06-30 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-06-30 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-06-30 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-06-30 | 0.00% |
